Soluble Complement Receptor Type I Limits Damage During Revascularization of Ischemic Myocardium

Background. This study was undertaken to determine whether suppression of complement activation with soluble human complement receptor type I reduces myocardial damage during the revascularization of ischemic myocardium. Methods. In 20 pigs, the second and third diagonal coronary arteries were occlu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Annals of thoracic surgery 1998-04, Vol.65 (4), p.973-977
Hauptverfasser:	Lazar, Harold L., Hamasaki, Takafumi, Bao, Yusheng, Rivers, Samuel, Bernard, Sheilah A., Shemin, Richard J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acidosis - etiology Acidosis - physiopathology Animals Biological and medical sciences Cardiomyopathies - etiology Cardiomyopathies - physiopathology Cardiovascular system Complement Activation - drug effects Complement Inactivator Proteins - administration & dosage Complement Inactivator Proteins - therapeutic use Coronary Disease - physiopathology Heart Arrest, Induced Hemolysis Humans Hydrogen-Ion Concentration Infusions, Intravenous Medical sciences Miscellaneous Myocardial Contraction - drug effects Myocardial Ischemia - pathology Myocardial Ischemia - physiopathology Myocardial Ischemia - therapy Myocardial Reperfusion Myocardial Reperfusion Injury - prevention & control Myocardium - pathology Necrosis Pharmacology. Drug treatments Random Allocation Receptors, Complement - administration & dosage Receptors, Complement - therapeutic use Swine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!